BioCentury
ARTICLE | Clinical News

Biosyn reports Phase I/II data

May 17, 2000 7:00 AM UTC

Biosyn (Philadelphia, Penn.) said its Oramed oral rinse to treat oral candidiasis in HIV/AIDS patients was safe and well tolerated. The placebo-controlled study also showed early signs of efficacy and...